DK0949250T3 - Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister - Google Patents

Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister

Info

Publication number
DK0949250T3
DK0949250T3 DK99105755T DK99105755T DK0949250T3 DK 0949250 T3 DK0949250 T3 DK 0949250T3 DK 99105755 T DK99105755 T DK 99105755T DK 99105755 T DK99105755 T DK 99105755T DK 0949250 T3 DK0949250 T3 DK 0949250T3
Authority
DK
Denmark
Prior art keywords
alpha1l
preparation
adrenoceptor antagonists
fluoro
chem
Prior art date
Application number
DK99105755T
Other languages
English (en)
Inventor
Robert Clark Chapman
Jolyon Perkins
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0949250T3 publication Critical patent/DK0949250T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK99105755T 1998-03-30 1999-03-22 Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister DK0949250T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7997498P 1998-03-30 1998-03-30

Publications (1)

Publication Number Publication Date
DK0949250T3 true DK0949250T3 (da) 2006-08-28

Family

ID=22153993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99105755T DK0949250T3 (da) 1998-03-30 1999-03-22 Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister

Country Status (10)

Country Link
US (1) US6156894A (da)
EP (1) EP0949250B1 (da)
JP (1) JP3276342B2 (da)
KR (1) KR100347469B1 (da)
CN (1) CN1136199C (da)
AT (1) ATE325104T1 (da)
CA (1) CA2267510C (da)
DE (1) DE69931100T2 (da)
DK (1) DK0949250T3 (da)
ES (1) ES2263238T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5127366B2 (ja) 2007-08-29 2013-01-23 富士通コンポーネント株式会社 情報処理装置、kvmスイッチ、サーバ及び制御プログラム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867456A (en) * 1965-07-30 1975-02-18 Oreal Mono-omega-haloalkyl amines
JPS5324952B2 (da) * 1973-11-28 1978-07-24
US5859014A (en) * 1995-06-09 1999-01-12 Syntex (U.S.A.) Inc. Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists
EP0748800B1 (en) * 1995-06-09 2001-05-09 F. Hoffmann-La Roche Ag Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists
HRP970239B1 (en) * 1997-05-09 2004-04-30 Inst Ru Er Bouekovic Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity

Also Published As

Publication number Publication date
CN1234398A (zh) 1999-11-10
CA2267510C (en) 2005-05-17
JPH11322724A (ja) 1999-11-24
KR19990078360A (ko) 1999-10-25
DE69931100T2 (de) 2007-04-19
EP0949250A1 (en) 1999-10-13
ATE325104T1 (de) 2006-06-15
JP3276342B2 (ja) 2002-04-22
CA2267510A1 (en) 1999-09-30
US6156894A (en) 2000-12-05
KR100347469B1 (ko) 2002-08-07
ES2263238T3 (es) 2006-12-01
EP0949250B1 (en) 2006-05-03
CN1136199C (zh) 2004-01-28
DE69931100D1 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
NO932870L (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
ES2188661T3 (es) Preparacion de un derivado de camptothecin por ciclacion intramolecular.
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
DK0503453T3 (da) Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
DE59910677D1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
ATE255103T1 (de) Verfahren zur herstellung von pyridinmethanol- verbindungen
ES2158425T3 (es) Procedimiento para la preparacion de derivados de pirimidina.
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
ATE266618T1 (de) Verfahren zur herstellung von zwischenprodukten für pestizide
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
DK0949250T3 (da) Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister
BR9503845A (pt) Processo para a preparação de um composto e composto obtido
NZ333229A (da)
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
MY130817A (en) Herbicides
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
DK0662475T3 (da) Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on.
ATE286058T1 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA